Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Larry Ereshefsky, PharmD, FCCP, BCCP
JCP
Original Research
Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Elderly Patients With Primary Insomnia: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
October 31, 2008
Martin Scharf
,
Roberta Rogowski
,
Steven Hull
, et al
JCP
Original Research
The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2003 Update
April 1, 2004
Alexander L. Miller
,
Catherine S. Hall
,
Robert W. Buchanan
, et al
JCP
Article
Clinical Guidelines: Dosing and Switching Strategies for Long-Acting Risperidone
November 1, 2003
Stephen R. Marder
,
Robert Conley
,
Larry Ereshefsky
, et al
JCP
Article
Comparison of the Effects of Different Routes of Antipsychotic Administration on Pharmacokinetics and Pharmacodynamics
November 1, 2003
Larry Ereshefsky
,
Cynthia A. Mascarenas
JCP
Article
Branded Versus Generic Clozapine: Bioavailability Comparison and Interchangeability Issues
April 1, 2001
Y. W. Francis Lam
,
Larry Ereshefsky
,
Gregory B. Toney
, et al
JCP
Article
Conclusion"Comparsion of the Bieoquvalence of Generic Versus Branded Clozapine"
April 1, 2001
Larry Ereshefsky
,
William M. Glazer
JCP
Article
Introduction: Comparison of the Bioequivalence of Generic Versus Branded Clozapine
April 1, 2001
Larry Ereshefsky
,
Marvin C. Meyer
JCP
Article
Pharmacologic and Pharmacokinetic Considerations in Choosing an Antipsychotic
October 1, 1999
Larry Ereshefsky
